Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam

We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing in a clinical setting, is now open. Please visit www.ccg2025.eu for more information, abstract submission or registration of your participation! 
 
An increasing number of European countries are adapting clinical cancer (gen)omics programs including whole genome and transcriptome sequencing (WGTS) to enable cancer precision medicine and support research and a learning health care system for improving future cancer care. 

This meeting will be the first of an annual recurring series and aims to bring together researchers and medical specialists involved in these programs or interested in genomics-based and data-driven cancer care and/or research. The current state-of-the-art implementations in routine care, research highlights, clinical impact and future developments will be presented and discussed. 
 
National programs in Europe supporting translation of genomics approaches from the clinic to research and back will be central to this meeting. The first meeting will take place on Thursday March 20 and Friday 21, 2025 in Amsterdam, the Netherlands, and is initiated as part of the 10th anniversary of Hartwig Medical Foundation. The meeting will be organised together with Genomics England, DKFZ German Cancer Research Center MASTER/NCT, Genomic Medicine Sweden, Plan France Médecine Génomique 2025 , and Danish National Genome Center.

You read an article in the category Research. You may also be interested in Hartwig Medical Foundation, Learning healthcare system, Molecular diagnostics, or Whole genome sequencing.
All news

Also read

Metastatic bladder cancer: new insights into tumour spread and chemotherapy resistance

Metastatic bladder cancer: new insights into tumour spread and chemotherapy resistance

25-09-2026

Hartwig data supports new Nature study on lethal metastatic bladder cancer. Researchers used the Hartwig Medical Database to independently validate …

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

New CPoC grant awarded: GLOW – GLioblastoma targeted treatment Option maximisation by WGS

27-05-2021

Oncode Institute has announced that the 13th grant within the Clinical Proof of Concept programme has been awarded. Oncode Investigator …

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice 

16-07-2024

By Laura Nederveen   In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl